Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by G1945Von Sep 15, 2022 8:13am
127 Views
Post# 34963827

RE:Life Changing Technology

RE:Life Changing Technology
Jennifer2020 wrote:
Practically all top heart institutes have a VMS unit now with Duke Univ. , Mazankowski Heart Institute, Stollery Children's Hosp. & Toronto's Children's Hosp mentioned in the last year. 15 important studies used VMS or are underway at places such as Harvard, King's College London and Cedar Sinai. Countries using VMS also include such places as China, Belgium and Switzerland. It's taken 10 years to develop VMS's patented KBR AI and Ventripoint is now partnered with a multi-billion dollar giant GE Health Care in the best of all circumstances in a non-exclusive agreement. The week of GEHC's Nasdaq debut has been announced and true auto Vivid 4D Echopac plus has been demonstrated and is going to be fully promoted as the spinco date approaches. The buyout price for VPT shareholders on CEO.CA range from $1 to $5 so we are looking at a minimum triple bagger from here.


https://www.nasdaq.com/articles/ge-announces-brand-names-for-future-public-companies-ge-aerospace-to-own-ge-trademark

"Following the completion of the planned spin-off, shares of GE HealthCare will be listed on the Nasdaq Global Select Market under the ticker symbol, GEHC."



Don't get left behind...DYODD...GLTA
G1945V

<< Previous
Bullboard Posts
Next >>